Venrock has raised $400 million for its Venrock Healthcare Capital Partners III cross-over biotech fund, according to an SEC filing posted this week. The total funds raised include a commitment from Venrock’s general partner, VHCP Management III, according to the SEC filing. Venrock has not yet released any detailed plans on how it will spend […]
April 17, 2015 by Scott Wooldridge
Spirox said this week that it nailed down an $18.5 million Series B round to back development and commercialization of its device to treat patients with nasal obstructions.
Venrock and Aisling Capital led the round for Menlo Park, Calif.-based Spirox, with existing investors Aperture Venture Partners, Correlation Ventures and Western Technology Investment also participating.
June 16, 2014 by Arezu Sarvestani
Ophthalmic devices maker PowerVision finally put a ribbon on its $30 million Series D funding round, planning on using the funds to advance clinical trials in support of regulatory approvals in Europe and the U.S.
California-based medtech group RefleXion Medical touted an $11.6 million Series A fundraising round, hoping to use the new funds to expand research & development efforts for its guided radiation therapy technology.